NO309229B1 - Fremgangsmåter for å ödelegge hydrogenperoksyd og desinfisering av kontaktlinse, samt komprimert tablettblanding - Google Patents
Fremgangsmåter for å ödelegge hydrogenperoksyd og desinfisering av kontaktlinse, samt komprimert tablettblanding Download PDFInfo
- Publication number
- NO309229B1 NO309229B1 NO953167A NO953167A NO309229B1 NO 309229 B1 NO309229 B1 NO 309229B1 NO 953167 A NO953167 A NO 953167A NO 953167 A NO953167 A NO 953167A NO 309229 B1 NO309229 B1 NO 309229B1
- Authority
- NO
- Norway
- Prior art keywords
- catalase
- hydrogen peroxide
- contact lens
- derived
- tablet
- Prior art date
Links
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 title claims abstract description 239
- 230000000249 desinfective effect Effects 0.000 title claims abstract description 34
- 238000000034 method Methods 0.000 title claims abstract description 34
- 239000007891 compressed tablet Substances 0.000 title claims abstract description 12
- 238000002156 mixing Methods 0.000 title 1
- 102000016938 Catalase Human genes 0.000 claims abstract description 91
- 108010053835 Catalase Proteins 0.000 claims abstract description 91
- 239000003826 tablet Substances 0.000 claims abstract description 27
- 101000867659 Bos taurus Catalase Proteins 0.000 claims abstract description 22
- 241000228245 Aspergillus niger Species 0.000 claims abstract description 20
- 230000006835 compression Effects 0.000 claims abstract description 9
- 238000007906 compression Methods 0.000 claims abstract description 9
- 239000007788 liquid Substances 0.000 claims description 72
- 239000000203 mixture Substances 0.000 claims description 51
- 230000006378 damage Effects 0.000 claims description 32
- 241000191938 Micrococcus luteus Species 0.000 claims description 24
- 230000004888 barrier function Effects 0.000 claims description 24
- 230000000694 effects Effects 0.000 claims description 23
- 230000003111 delayed effect Effects 0.000 claims description 13
- 244000005700 microbiome Species 0.000 claims description 11
- 239000008187 granular material Substances 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 9
- 238000000576 coating method Methods 0.000 claims description 8
- 239000011248 coating agent Substances 0.000 claims description 7
- 239000002245 particle Substances 0.000 claims description 6
- 230000001934 delay Effects 0.000 claims description 5
- 239000006187 pill Substances 0.000 claims description 5
- 238000000354 decomposition reaction Methods 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 2
- 239000011159 matrix material Substances 0.000 claims 3
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 238000002360 preparation method Methods 0.000 abstract description 33
- 239000007916 tablet composition Substances 0.000 abstract 2
- 101710116791 Catalase R Proteins 0.000 abstract 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 abstract 1
- 239000000600 sorbitol Substances 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 description 35
- 108090000790 Enzymes Proteins 0.000 description 35
- 229940088598 enzyme Drugs 0.000 description 35
- 239000000243 solution Substances 0.000 description 34
- 230000009471 action Effects 0.000 description 13
- 238000004140 cleaning Methods 0.000 description 13
- 239000000645 desinfectant Substances 0.000 description 12
- 239000007942 layered tablet Substances 0.000 description 12
- 102000004169 proteins and genes Human genes 0.000 description 11
- 108090000623 proteins and genes Proteins 0.000 description 11
- 238000004519 manufacturing process Methods 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 9
- 238000004659 sterilization and disinfection Methods 0.000 description 9
- 239000000872 buffer Substances 0.000 description 7
- 206010015946 Eye irritation Diseases 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 231100000013 eye irritation Toxicity 0.000 description 6
- 108010056079 Subtilisins Proteins 0.000 description 5
- 102000005158 Subtilisins Human genes 0.000 description 5
- -1 alkaline earth metal salts Chemical class 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 235000014469 Bacillus subtilis Nutrition 0.000 description 4
- 108091005658 Basic proteases Proteins 0.000 description 4
- 102000035195 Peptidases Human genes 0.000 description 4
- 108091005804 Peptidases Proteins 0.000 description 4
- 108090000787 Subtilisin Proteins 0.000 description 4
- 239000010410 layer Substances 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- 230000005587 bubbling Effects 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 102000013142 Amylases Human genes 0.000 description 2
- 108010065511 Amylases Proteins 0.000 description 2
- 241000228212 Aspergillus Species 0.000 description 2
- 108091005507 Neutral proteases Proteins 0.000 description 2
- 102000035092 Neutral proteases Human genes 0.000 description 2
- 241000228150 Penicillium chrysogenum Species 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 235000019418 amylase Nutrition 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 239000012263 liquid product Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- 102000004400 Aminopeptidases Human genes 0.000 description 1
- 108090000915 Aminopeptidases Proteins 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 108090000145 Bacillolysin Proteins 0.000 description 1
- 241000193744 Bacillus amyloliquefaciens Species 0.000 description 1
- 241000194108 Bacillus licheniformis Species 0.000 description 1
- 241000194103 Bacillus pumilus Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 108010006035 Metalloproteases Proteins 0.000 description 1
- 102000005741 Metalloproteases Human genes 0.000 description 1
- 241000192041 Micrococcus Species 0.000 description 1
- 101000715502 Micrococcus luteus Catalase Proteins 0.000 description 1
- 241000194105 Paenibacillus polymyxa Species 0.000 description 1
- 108010067372 Pancreatic elastase Proteins 0.000 description 1
- 102000016387 Pancreatic elastase Human genes 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 108010059712 Pronase Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 241000015473 Schizothorax griseus Species 0.000 description 1
- 108010022999 Serine Proteases Proteins 0.000 description 1
- 102000012479 Serine Proteases Human genes 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 125000002877 alkyl aryl group Chemical group 0.000 description 1
- 229940025131 amylases Drugs 0.000 description 1
- 108090000987 aspergillopepsin I Proteins 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical group OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000007975 buffered saline Substances 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 125000005587 carbonate group Chemical group 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical group OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000011247 coating layer Substances 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 239000000882 contact lens solution Substances 0.000 description 1
- 239000000599 controlled substance Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000012792 core layer Substances 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 108010007093 dispase Proteins 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 229920001821 foam rubber Polymers 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 108010059345 keratinase Proteins 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 108090000021 oryzin Proteins 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 239000008247 solid mixture Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 229960001322 trypsin Drugs 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 239000012224 working solution Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
- A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
- A61L12/12—Non-macromolecular oxygen-containing compounds, e.g. hydrogen peroxide or ozone
- A61L12/124—Hydrogen peroxide; Peroxy compounds
- A61L12/126—Hydrogen peroxide; Peroxy compounds neutralised with catalase or peroxidase
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/911—Microorganisms using fungi
- Y10S435/913—Aspergillus
- Y10S435/917—Aspergillus niger
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
- Eyeglasses (AREA)
- Oxygen, Ozone, And Oxides In General (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Detergent Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Enzymes And Modification Thereof (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/017,232 US5362647A (en) | 1993-02-12 | 1993-02-12 | Compositions and methods for destroying hydrogen peroxide |
| PCT/US1994/001428 WO1994017833A1 (en) | 1993-02-12 | 1994-02-09 | Compositions and methods for destroying hydrogen peroxide |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO953167D0 NO953167D0 (no) | 1995-08-11 |
| NO953167L NO953167L (no) | 1995-10-11 |
| NO309229B1 true NO309229B1 (no) | 2001-01-02 |
Family
ID=21781478
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO953167A NO309229B1 (no) | 1993-02-12 | 1995-08-11 | Fremgangsmåter for å ödelegge hydrogenperoksyd og desinfisering av kontaktlinse, samt komprimert tablettblanding |
Country Status (22)
| Country | Link |
|---|---|
| US (3) | US5362647A (de) |
| EP (2) | EP0683677B1 (de) |
| JP (1) | JPH08506505A (de) |
| KR (1) | KR100297165B1 (de) |
| CN (1) | CN1104912C (de) |
| AT (2) | ATE243046T1 (de) |
| AU (1) | AU686599B2 (de) |
| BR (1) | BR9405701A (de) |
| CA (1) | CA2155948C (de) |
| DE (2) | DE69432828T2 (de) |
| ES (2) | ES2199118T3 (de) |
| FI (1) | FI953817A0 (de) |
| HU (1) | HU216906B (de) |
| IL (1) | IL108579A (de) |
| NO (1) | NO309229B1 (de) |
| NZ (1) | NZ262047A (de) |
| PH (1) | PH29920A (de) |
| PL (1) | PL180123B1 (de) |
| RU (1) | RU2126273C1 (de) |
| TW (1) | TW283086B (de) |
| WO (1) | WO1994017833A1 (de) |
| ZA (1) | ZA94954B (de) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5556480A (en) * | 1991-05-07 | 1996-09-17 | Dirygesa, S.L. | Procedure for disinfecting and cleaning contact lenses |
| JPH08507700A (ja) * | 1992-12-28 | 1996-08-20 | ボシュ アンド ロム インコーポレイテッド | 水性媒体内に活性物質を制御放出する組成物 |
| US5362647A (en) * | 1993-02-12 | 1994-11-08 | Allergan, Inc. | Compositions and methods for destroying hydrogen peroxide |
| IL109705A (en) * | 1993-06-17 | 1998-07-15 | Allergan Inc | Enzyme compositions and methods for contact lens cleaning |
| US5783532A (en) * | 1993-06-17 | 1998-07-21 | Allergan | Enzyme compositions and methods for contact lens cleaning |
| DE4432621A1 (de) * | 1994-09-14 | 1996-03-21 | Huels Chemische Werke Ag | Verfahren zur Bleichung von Tensidlösungen |
| EP0853533A1 (de) * | 1995-10-06 | 1998-07-22 | Novo Nordisk A/S | Bleichen und sterilizieren von korkartikeln |
| US5897833A (en) * | 1996-09-30 | 1999-04-27 | Allergan | Systems and methods for disinfecting contact lenses |
| US5746972A (en) * | 1996-11-01 | 1998-05-05 | Allergan | Compositions and methods for disinfecting and cleaning contact lenses |
| US6022721A (en) * | 1997-01-03 | 2000-02-08 | Development Center For Biotechnology | Catalase, the gene thereof and composition comprising the same, and process for preparing catalase using genetic engineering technology |
| KR100211674B1 (ko) * | 1997-02-25 | 1999-08-02 | 윤종용 | 과산화수소에 저항성을 갖는 신규 미생물 |
| EP0968003B1 (de) * | 1997-02-28 | 2002-06-05 | Albert Sturm | Wasserlösliches festes kontaktlinsenpflegemittel |
| US6022732A (en) * | 1997-04-09 | 2000-02-08 | Allergan | Hydrogen peroxide destroying compositions and methods of using same |
| KR20040037009A (ko) * | 2002-10-25 | 2004-05-04 | (주) 피엘바이오 | 과산화수소수 분해 능력과 저항성이 이 뛰어난 신규미생물과 이들이 생산하는 카타라아제 |
| US7211249B2 (en) * | 2003-03-17 | 2007-05-01 | Color Access, Inc. | Heat-generating composition for topical application to skin |
| GEP20084406B (en) * | 2003-05-30 | 2008-06-25 | Ranbaxy Lab Ltd | Substituted pyrrole derivatives and their use as hmg-co inhibitors |
| US7860012B2 (en) * | 2007-12-18 | 2010-12-28 | Michael Asher | Employing parallel processing for routing calls |
| US8960901B2 (en) | 2009-02-02 | 2015-02-24 | Johnson & Johnson Vision Care, Inc. | Myopia control ophthalmic lenses |
| US8172256B2 (en) * | 2009-03-16 | 2012-05-08 | Ami Amos Fine | Cart |
| CA2775969C (en) * | 2009-11-17 | 2016-12-20 | Novartis Ag | A hydrogen peroxide solution and kit for disinfecting contact lenses |
| JP2013519101A (ja) | 2010-02-08 | 2013-05-23 | グルメトリクス， インコーポレイテッド | 化学センサーの抗酸化剤保護 |
| DK2645987T3 (en) | 2010-12-01 | 2016-01-11 | Brain Biotechnology Res & Information Network Ag | New Catalases |
| DE102012206635A1 (de) * | 2012-04-23 | 2013-10-24 | Krones Ag | Einsatz von Katalase in Abfüllmaschinen |
| RU2488630C1 (ru) * | 2012-05-11 | 2013-07-27 | Общество с ограниченной ответственностью "Петербургские Биотехнологии" | ШТАММ Micrococcus luteus, ОБЛАДАЮЩИЙ КАТАЛАЗНОЙ АКТИВНОСТЬЮ И ОСУЩЕСТВЛЯЮЩИЙ ТРАНСФОРМАЦИИ ОРГАНИЧЕСКИХ ОСТАТКОВ ПРИРОДНОГО ПРОИСХОЖДЕНИЯ |
| US9826735B2 (en) | 2012-08-03 | 2017-11-28 | Toyo Seikan Group Holdings, Ltd. | Peracetic acid type sterilizing composition solution and method for sterilizing containers |
| US9439990B2 (en) | 2013-07-23 | 2016-09-13 | Abbott Medical Optics Inc. | Leak-proof contact lens container |
| US10478518B2 (en) * | 2016-03-02 | 2019-11-19 | Better Vision Solutions LLC | Method for disinfecting contact lenses |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3123539A (en) * | 1964-03-03 | Process for recovering catalase from | ||
| US2635069A (en) * | 1947-11-25 | 1953-04-14 | Ben L Sarett | Production of catalase from mold |
| DE2308013A1 (de) * | 1973-02-17 | 1974-09-12 | Behringwerke Ag | Katalasearme glucoseoxidase und verfahren zu ihrer gewinnung |
| EP0082798B2 (de) * | 1981-12-21 | 1991-11-27 | Ciba-Geigy Ag | Verfahren zur Desinfektion und Reinigung von Kontaktlinsen |
| US4588586A (en) * | 1983-01-03 | 1986-05-13 | Kessler Jack H | Method for disinfecting a contact lens |
| GB8515079D0 (en) * | 1985-06-14 | 1985-07-17 | Kellway Pharma | Contact lens cleaning & disinfection |
| DE3666914D1 (en) * | 1985-07-10 | 1989-12-21 | Ciba Geigy Ag | Cleaning set for contact lenses |
| USRE32672E (en) * | 1985-09-09 | 1988-05-24 | Allergan, Inc. | Method for simultaneously cleaning and disinfecting contact lenses using a mixture of peroxide and proteolytic enzyme |
| DE3626082A1 (de) * | 1986-07-31 | 1988-02-11 | Henkel Kgaa | Desinfektions- und reinigungsmittelsystem fuer kontaktlinsen |
| US4959212A (en) * | 1988-06-22 | 1990-09-25 | Alexandra Stancesco | Oxidizing-energizing composition and method for the treatment of diabetes |
| SE8901279D0 (sv) * | 1989-04-10 | 1989-04-10 | Pharmacia Ab | Komposition |
| JPH03143598A (ja) * | 1989-10-26 | 1991-06-19 | Kurita Water Ind Ltd | 過酸化水素含有排水の処理方法 |
| US5080886A (en) * | 1990-01-05 | 1992-01-14 | Sterling Drug Inc. | Pharmaceutical compositions for the prevention and treatment of oxidant injuries |
| US5145644A (en) * | 1990-12-20 | 1992-09-08 | Allergan, Inc. | Hydrogen peroxide destroying compositions and methods of making and using same |
| EP0580662B1 (de) * | 1991-03-27 | 1998-06-10 | Novo Nordisk A/S | Katalase, ihre herstellung und verwendung |
| US5521291A (en) * | 1991-09-30 | 1996-05-28 | Boehringer Ingelheim International, Gmbh | Conjugates for introducing nucleic acid into higher eucaryotic cells |
| ES2263246T3 (es) * | 1992-03-04 | 2006-12-01 | Genencor International, Inc. | Uso de catalasa de aspergillus niger para neutralizar peroxido e hidrogeno. |
| US5360901A (en) * | 1992-03-04 | 1994-11-01 | Genencor International, Inc. | Gene sequence encoding Aspergillus niger catalase-R |
| US5360732A (en) * | 1992-03-04 | 1994-11-01 | Genecor International, Inc. | Production of Aspergillus niger catalase-R |
| US5362647A (en) * | 1993-02-12 | 1994-11-08 | Allergan, Inc. | Compositions and methods for destroying hydrogen peroxide |
-
1993
- 1993-02-12 US US08/017,232 patent/US5362647A/en not_active Expired - Fee Related
-
1994
- 1994-02-07 PH PH47714A patent/PH29920A/en unknown
- 1994-02-07 IL IL108579A patent/IL108579A/xx not_active IP Right Cessation
- 1994-02-09 ES ES00202511T patent/ES2199118T3/es not_active Expired - Lifetime
- 1994-02-09 DE DE69432828T patent/DE69432828T2/de not_active Expired - Fee Related
- 1994-02-09 WO PCT/US1994/001428 patent/WO1994017833A1/en active IP Right Grant
- 1994-02-09 DE DE69432806T patent/DE69432806T2/de not_active Expired - Fee Related
- 1994-02-09 CA CA002155948A patent/CA2155948C/en not_active Expired - Fee Related
- 1994-02-09 AU AU61548/94A patent/AU686599B2/en not_active Ceased
- 1994-02-09 ES ES94908012T patent/ES2199225T3/es not_active Expired - Lifetime
- 1994-02-09 HU HU9502001A patent/HU216906B/hu not_active IP Right Cessation
- 1994-02-09 BR BR9405701A patent/BR9405701A/pt not_active IP Right Cessation
- 1994-02-09 CN CN94191163A patent/CN1104912C/zh not_active Expired - Fee Related
- 1994-02-09 AT AT94908012T patent/ATE243046T1/de not_active IP Right Cessation
- 1994-02-09 NZ NZ262047A patent/NZ262047A/en unknown
- 1994-02-09 JP JP6518321A patent/JPH08506505A/ja not_active Ceased
- 1994-02-09 EP EP94908012A patent/EP0683677B1/de not_active Expired - Lifetime
- 1994-02-09 EP EP00202511A patent/EP1050313B1/de not_active Expired - Lifetime
- 1994-02-09 KR KR1019950703368A patent/KR100297165B1/ko not_active IP Right Cessation
- 1994-02-09 AT AT00202511T patent/ATE242015T1/de not_active IP Right Cessation
- 1994-02-09 RU RU95118443A patent/RU2126273C1/ru not_active IP Right Cessation
- 1994-02-09 PL PL94310164A patent/PL180123B1/pl not_active IP Right Cessation
- 1994-02-11 ZA ZA94954A patent/ZA94954B/xx unknown
- 1994-02-19 TW TW083101409A patent/TW283086B/zh active
- 1994-06-13 US US08/259,207 patent/US5521091A/en not_active Expired - Fee Related
-
1995
- 1995-08-11 NO NO953167A patent/NO309229B1/no unknown
- 1995-08-11 FI FI953817A patent/FI953817A0/fi unknown
-
1996
- 1996-12-27 US US08/773,425 patent/US5766931A/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO309229B1 (no) | Fremgangsmåter for å ödelegge hydrogenperoksyd og desinfisering av kontaktlinse, samt komprimert tablettblanding | |
| US5260021A (en) | Hydrogen peroxide-containing gels and contact lens disinfecting using same | |
| CA2095022C (en) | Compositions and methods for identifying a solution | |
| NO163843B (no) | Fremgangsmaate for rengjoering og desinfisering av kontaktlinser. | |
| US5338480A (en) | Compositions and methods to clean contact lenses | |
| US5746972A (en) | Compositions and methods for disinfecting and cleaning contact lenses | |
| EP0426489A2 (de) | Zusammensetzungen zur Zersetzung von Wasserstoffperoxid und Verfahren zu deren Verwendung | |
| CA2154179C (en) | Compositions and methods to disinfect contact lenses | |
| EP0517758B1 (de) | Wasserstoffperoxid zersetzende zusammensetzungen und verfahren zur herstellung und verwendung derselben | |
| WO1997029788A1 (en) | Compositions and methods for enzyme deactivation | |
| WO1995027515A1 (en) | Phospholipid preservation of hydrogen peroxide-containing compositions |